{
  "id": 3251919,
  "title": "Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium",
  "url": "https://urgent.news/2026/08/25/kane-biotechs-revyve-research-presented-at-military-health-system",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-25T11:25:25.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/kane-biotechs-revyve-research-presented-at-military-health-system-research-symposium"
  },
  "original_language": "en",
  "account": null,
  "summary": "Presentation addressed potential applications in prolonged field care and military wound management settings WINNIPEG, Manitoba, Aug. 25, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announced today that research regarding its revyve antimicrobial wound care technology was presented at the Military Health System Research Symposium (MHSRS), held…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}